National and Kapodistrian University of Athens
Νευροχημικά και απεικονιστικά χαρακτηριστικά ασθενών με επαυξημένα παρκινσονικά σύνδρομα
Abstract
dc:descriptionIntroduction: Differential diagnosis of Parkinson-plus syndromes is often difficult, particularly in atypical cases as well as early in the disease course. Established clinical diagnostic criteria lack sensitivity, and in the case of corticobasal degeneration (CBD) also specificity. Reliable biomarkers are needed to assist in a more accurate and earlier diagnosis of patients with Parkinsonism. Patients and Methods: Nineteen patients with progressive supranuclear palsy (PSP), 15 patients with multiple system atrophy (MSA) and 17 patients with CBD were included. For imaging data, 11 patients with Parkinson’s disease (PD) and 12 healthy controls were included. For biochemical CSF data, 17 PD and 18 healthy controls were included. All patients underwent thorough neurological examination and neuropsychological testing. Neurological history and disease course data were included. The following CSF biomarkers were measured: b-amyloid (Αβ42), total tau protein (τT), phosphorylated tau protein (τP-181) and a-synuclein (α-syn). A multitude of imaging indices, including simple MRI distances, surface measurements as well as specific imaging signs were recorded. Results: There is considerable clinical overlap among Parkinson-plus patients. The presence of stridor, RBD and cerebellar signs are specific for MSA. Likewise, stereoagnosia and sensory hemineglect are characteristic of CBD, and visual hypometria of PSP. The Goldenberg apraxia test reliably quantitates apraxia and is particularly useful in CBD diagnosis. The Magnetic Resonance Parkinsonism Index (MRPI), is a potent marker of PSP. The midbrain x superior cerebellar peduncle (SCP) width product also provides excellent specificity and sensitivity for the diagnosis of PSP. Five patients (29%) fullfiling probable CBD criteria harnored an Alzheimer’s disease (AD) biochemical profile. Elevated τΤ and decreased Αβ42 in CBD patients could be attributed to the admixture of AD patients with a corticobasal syndrome phenotype. An elevated τΤ /Αβ42 ratio can assist in the differentiation of MSA from PD. Conclusions: The implementation of simple MRI distances and surfaces measurements, as well as analysis of biochemical CSF profile can assist in the differential diagnosis of Parkinson-plus patients.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2018
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Constantinides, Vasilios
- Κωνσταντινίδης, Βασίλειος
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/42486